Phase 2 Alopecia Areata Trial, Recruiting NCT07370519 Sponsor: Shenzhen People's Hospital Condition: Alopecia Areata
Back to Alopecia Areata

Phase 2 Alopecia Areata Trial, Recruiting

NCT07370519
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with a common type of hair loss (known as pattern baldness) confirmed by your medical history, appearance, and a scalp examination, and your hair loss falls within a mild-to-moderate range on standard grading scales
  • You are willing to take part and have given your written agreement to join the trial
  • You are between 18 and 60 years old and are generally in good health
  • You have not used any hair loss treatments or medications in the past six months
  • You do not have patchy hair loss (alopecia areata), any active scalp infections, or nerve/muscle conditions

Who may not be able to join:

  • Your hair loss has been progressing for more than 5 years
  • You currently have an active skin condition (such as a psoriasis flare-up) or have diabetes or a heart/blood vessel condition that is not well controlled
  • The trial investigator decides, for any reason, that the trial would not be suitable or practical for you (confirm with trial site)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: +86 13873143466

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Shenzhen People's Hospital
Registry
ClinicalTrials.gov
Start date
25 January 2026
Est. completion
1 January 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Hair Density

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov